Insufficient scRNA-seq data for expression of CD177 at single-cell level.
Insufficient scRNA-seq data for expression of CD177 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 82% | 2430.71 | 201 / 245 | 83% | 76.15 | 416 / 502 |
lung | 80% | 1669.22 | 462 / 578 | 39% | 17.18 | 451 / 1155 |
spleen | 95% | 5069.46 | 229 / 241 | 0% | 0 | 0 / 0 |
intestine | 39% | 1849.17 | 374 / 966 | 51% | 21.79 | 269 / 527 |
peripheral blood | 81% | 40346.77 | 752 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 34.75 | 30 / 45 |
esophagus | 15% | 61.85 | 222 / 1445 | 48% | 19.82 | 87 / 183 |
stomach | 16% | 82.32 | 56 / 359 | 47% | 29.22 | 134 / 286 |
breast | 22% | 83.47 | 102 / 459 | 21% | 11.60 | 238 / 1118 |
adipose | 40% | 247.05 | 483 / 1204 | 0% | 0 | 0 / 0 |
uterus | 11% | 62.51 | 18 / 170 | 29% | 7.02 | 134 / 459 |
bladder | 10% | 19.33 | 2 / 21 | 30% | 9.50 | 151 / 504 |
thymus | 14% | 42.92 | 91 / 653 | 24% | 12.22 | 145 / 605 |
pancreas | 4% | 9.60 | 13 / 328 | 31% | 6.16 | 55 / 178 |
liver | 26% | 110.02 | 59 / 226 | 6% | 0.96 | 24 / 406 |
kidney | 19% | 94.89 | 17 / 89 | 8% | 2.20 | 69 / 901 |
heart | 22% | 84.53 | 187 / 861 | 0% | 0 | 0 / 0 |
ovary | 4% | 7.95 | 7 / 180 | 13% | 1.01 | 58 / 430 |
skin | 2% | 6.47 | 36 / 1809 | 13% | 2.04 | 62 / 472 |
blood vessel | 14% | 61.00 | 181 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 1.20 | 10 / 80 |
brain | 9% | 23.62 | 241 / 2642 | 1% | 0.10 | 7 / 705 |
muscle | 6% | 13.68 | 46 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 5% | 12.90 | 12 / 258 | 1% | 0.21 | 2 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990266 | Biological process | neutrophil migration |
GO_0098742 | Biological process | cell-cell adhesion via plasma-membrane adhesion molecules |
GO_0045087 | Biological process | innate immune response |
GO_2001044 | Biological process | regulation of integrin-mediated signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0034394 | Biological process | protein localization to cell surface |
GO_0043315 | Biological process | positive regulation of neutrophil degranulation |
GO_0072672 | Biological process | neutrophil extravasation |
GO_0030100 | Biological process | regulation of endocytosis |
GO_0032930 | Biological process | positive regulation of superoxide anion generation |
GO_0045217 | Biological process | cell-cell junction maintenance |
GO_0007159 | Biological process | leukocyte cell-cell adhesion |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0044853 | Cellular component | plasma membrane raft |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0098552 | Cellular component | side of membrane |
GO_0030027 | Cellular component | lamellipodium |
GO_0005178 | Molecular function | integrin binding |
GO_0002020 | Molecular function | protease binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD177 |
Protein name | Putative CD177 protein CD177 molecule CD177 antigen (Human neutrophil alloantigen 2a) (HNA-2a) (NB1 glycoprotein) (NB1 GP) (Polycythemia rubra vera protein 1) (PRV-1) (CD antigen CD177) CD177 |
Synonyms | PRV1 UNQ595/PRO1181 NB1 |
Description | FUNCTION: In association with beta-2 integrin heterodimer ITGAM/CD11b and ITGB2/CD18, mediates activation of TNF-alpha primed neutrophils including degranulation and superoxide production . In addition, by preventing beta-2 integrin internalization and attenuating chemokine signaling favors adhesion over migration . Heterophilic interaction with PECAM1 on endothelial cells plays a role in neutrophil transendothelial migration in vitro . However, appears to be dispensable for neutrophil recruitment caused by bacterial infection in vivo . Acts as a receptor for the mature form of protease PRTN3 allowing its display at the cell surface of neutrophils . By displaying PRTN3 at the neutrophil cell surface, may play a role in enhancing endothelial cell junctional integrity and thus vascular integrity during neutrophil diapedesis . . |
Accessions | Q8N6Q3 Q1T7A3 D2N288 ENST00000618265.5 ENST00000378012.3 [Q8N6Q3-3] A0A087X113 ENST00000607855.5 A0A087WVM2 |